Annual Accounts Payable
$7.17 M
+$6.05 M+538.14%
01 July 2024
Summary:
BriaCell Therapeutics annual accounts payable is currently $7.17 million, with the most recent change of +$6.05 million (+538.14%) on 01 July 2024. During the last 3 years, it has risen by +$6.96 million (+3249.28%). BCTX annual accounts payable is now at all-time high.BCTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$7.17 M
+$748.40 K+11.65%
01 July 2024
Summary:
BriaCell Therapeutics quarterly accounts payable is currently $7.17 million, with the most recent change of +$748.40 thousand (+11.65%) on 01 July 2024. Over the past year, it has increased by +$6.74 million (+1552.64%). BCTX quarterly accounts payable is now at all-time high.BCTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCTX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +538.1% | +1552.6% |
| 3 y3 years | +3249.3% | - |
| 5 y5 years | - | - |
BCTX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +3249.3% | at high | +1552.6% |
| 5 y | 5 years | at high | +3249.3% | at high | +3249.3% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
BriaCell Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | $7.17 M(+538.1%) | $7.17 M(+11.7%) |
| Apr 2024 | - | $6.42 M(+73.0%) |
| Jan 2024 | - | $3.71 M(+755.4%) |
| Oct 2023 | - | $433.90 K(-61.4%) |
| July 2023 | $1.12 M(+142.5%) | $1.12 M(+12.9%) |
| Apr 2023 | - | $995.30 K(+70.9%) |
| Jan 2023 | - | $582.50 K(-26.4%) |
| Oct 2022 | - | $791.70 K(+70.9%) |
| July 2022 | $463.30 K(+116.4%) | $463.30 K(+116.4%) |
| July 2021 | $214.10 K | $214.10 K(+7282.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2008 | - | $2900.00(-81.4%) |
| July 2008 | $15.60 K(+62.5%) | $15.60 K(+437.9%) |
| Apr 2008 | - | $2900.00(-39.6%) |
| Jan 2008 | - | $4800.00(-63.4%) |
| Oct 2007 | - | $13.10 K(+36.5%) |
| July 2007 | $9600.00(-41.8%) | $9600.00(+380.0%) |
| Apr 2007 | - | $2000.00(+566.7%) |
| Jan 2007 | - | $300.00(-97.2%) |
| Oct 2006 | - | $10.90 K |
| July 2006 | $16.50 K | - |
FAQ
- What is BriaCell Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for BriaCell Therapeutics?
- What is BriaCell Therapeutics annual accounts payable year-on-year change?
- What is BriaCell Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for BriaCell Therapeutics?
- What is BriaCell Therapeutics quarterly accounts payable year-on-year change?
What is BriaCell Therapeutics annual accounts payable?
The current annual accounts payable of BCTX is $7.17 M
What is the all time high annual accounts payable for BriaCell Therapeutics?
BriaCell Therapeutics all-time high annual accounts payable is $7.17 M
What is BriaCell Therapeutics annual accounts payable year-on-year change?
Over the past year, BCTX annual accounts payable has changed by +$6.05 M (+538.14%)
What is BriaCell Therapeutics quarterly accounts payable?
The current quarterly accounts payable of BCTX is $7.17 M
What is the all time high quarterly accounts payable for BriaCell Therapeutics?
BriaCell Therapeutics all-time high quarterly accounts payable is $7.17 M
What is BriaCell Therapeutics quarterly accounts payable year-on-year change?
Over the past year, BCTX quarterly accounts payable has changed by +$6.74 M (+1552.64%)